[Gene therapy of prostate carcinoma].
Brill
T
T
Institut für Experimentelle Onkologie und Therapieforschung, Klinikum r.d. Isar der TU München, Ismaninger Strasse 22, 81675 München. thomas.brill@lrz.tum.de
Barba
M
M
Breul
J
J
Gänsbacher
B
B
D019496:Cancer Vaccines; D002986:Clinical Trials as Topic; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D008297:Male; D011355:Prodrugs; D011471:Prostatic Neoplasms / Q000235:genetics / Q000628:therapy*; D014780:Viruses
D019496:Cancer Vaccines; D011355:Prodrugs